The DOI matches its Crossref record.
Sarco(endo)plasmic Reticulum Calcium ATPase (SERCA) Inhibition by Sarcolipin Is Encoded in Its Luminal Tail
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonetheless, spectroscopic (27) and truncation/mutation (3, 28) studies in conjunction with functional assays indicated that both termini play a critical role in uncoupling ATP hydrolysis from Ca2+ transport via direct physical interactions with SERCA.”
From Structural basis for sarcolipin’s regulation of muscle thermogenesis by the sarcoplasmic reticulum Ca 2+ -ATPase (2021) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 61
- Wawrzynow, 1992, Sarcolipin, the “proteolipid” of skeletal muscle sarcoplasmic reticulum, is a unique, amphipathic, 31-residue peptide, Arch. Biochem. Biophys., 298, 620, 10.1016/0003-9861(92)90457-8 · DOI
- Bal, 2012, Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals, Nat. Med., 18, 1575, 10.1038/nm.2897 · DOI · Paper page
- Minamisawa, 2003, Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling, J. Biol. Chem., 278, 9570, 10.1074/jbc.M213132200 · DOI
- Babu, 2007, Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology, J. Mol. Cell. Cardiol., 43, 215, 10.1016/j.yjmcc.2007.05.009 · DOI
- Odermatt, 1997, Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease, Genomics, 45, 541, 10.1006/geno.1997.4967 · DOI · Paper page
- Vangheluwe, 2005, Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species, Biochem. J., 389, 151, 10.1042/BJ20050068 · DOI
- Asahi, 2003, Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban, Proc. Natl. Acad. Sci. U.S.A., 100, 5040, 10.1073/pnas.0330962100 · DOI · Paper page
- Simmerman, 1986, Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains, J. Biol. Chem., 261, 13333, 10.1016/S0021-9258(18)69309-3 · doi:10.1016/s0021-9258(18)69309-3
- Odermatt, 1998, Sarcolipin regulates the activity of SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase, J. Biol. Chem., 273, 12360, 10.1074/jbc.273.20.12360 · DOI · Paper page
- Waggoner, 2007, Phospholamban inhibits Ca-ATPase conformational changes involving the E2 intermediate, Biochemistry, 46, 1999, 10.1021/bi061365k · DOI
- Chen, 2010, Ca2+ binding to site I of the cardiac Ca2+ pump is sufficient to dissociate phospholamban, J. Biol. Chem., 285, 3253, 10.1074/jbc.M109.080820 · doi:10.1074/jbc.m109.080820
- Negash, 2000, Phospholamban remains associated with the Ca2+- and Mg2+-dependent ATPase following phosphorylation by cAMP-dependent protein kinase, Biochem. J., 351, 195, 10.1042/bj3510195 · doi:10.1042/bj3510195
- Traaseth, 2006, Effects of Ser16 phosphorylation on the allosteric transitions of phospholamban/Ca2+-ATPase complex, J. Mol. Biol., 358, 1041, 10.1016/j.jmb.2006.02.047 · DOI
- Karim, 2006, Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA, J. Mol. Biol., 358, 1032, 10.1016/j.jmb.2006.02.051 · DOI · Paper page
- Sasaki, 1992, Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic reticulum. Effects of synthetic phospholamban peptides on Ca2+ pump ATPase, J. Biol. Chem., 267, 1674, 10.1016/S0021-9258(18)45998-4 · DOI · Paper page
- Reddy, 1995, Functional reconstitution of recombinant phospholamban with rabbit skeletal Ca2+-ATPase, J. Biol. Chem., 270, 9390, 10.1074/jbc.270.16.9390 · doi:10.1074/jbc.270.16.9390
- Bhupathy, 2009, Threonine-5 at the N-terminus can modulate sarcolipin function in cardiac myocytes, J. Mol. Cell. Cardiol., 47, 723, 10.1016/j.yjmcc.2009.07.014 · DOI
- Gramolini, 2004, Sarcolipin retention in the endoplasmic reticulum depends on its C-terminal RSYQY sequence and its interaction with sarco(endo)plasmic Ca2+-ATPases, Proc. Natl. Acad. Sci. U.S.A, 101, 16807, 10.1073/pnas.0407815101 · DOI
- Hughes, 2007, Solid-state NMR and functional measurements indicate that the conserved tyrosine residues of sarcolipin are involved directly in the inhibition of SERCA1, J. Biol. Chem., 282, 26603, 10.1074/jbc.M611668200 · DOI · Paper page
- Tupling, 2002, Sarcolipin overexpression in rat slow twitch muscle inhibits sarcoplasmic reticulum Ca2+ uptake and impairs contractile function, J. Biol. Chem., 277, 44740, 10.1074/jbc.M206171200 · DOI
- Babu, 2006, Targeted overexpression of sarcolipin in the mouse heart decreases sarcoplasmic reticulum calcium transport and cardiac contractility, J. Biol. Chem., 281, 3972, 10.1074/jbc.M508998200 · DOI
- Gramolini, 2006, Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation, Proc. Natl. Acad. Sci. U.S.A, 103, 2446, 10.1073/pnas.0510883103 · DOI
- Autry, 2011, Oligomeric Interactions of Sarcolipin and the Ca-ATPase, J. Biol. Chem., 286, 31697, 10.1074/jbc.M111.246843 · doi:10.1074/jbc.m111.246843
- Hellstern, 2001, Sarcolipin, the shorter homologue of phospholamban, forms oligomeric structures in detergent micelles and in liposomes, J. Biol. Chem., 276, 30845, 10.1074/jbc.M102495200 · DOI
- Afara, 2008, Peptide inhibitors use two related mechanisms to alter the apparent calcium affinity of the sarcoplasmic reticulum calcium pump, Biochemistry, 47, 9522, 10.1021/bi800880q · doi:10.1021/bi800880q
- Warren, 1974, Reconstitution of a calcium pump using defined membrane components, Proc. Natl. Acad. Sci. U.S.A, 71, 622, 10.1073/pnas.71.3.622 · DOI · Paper page
- Trieber, 2005, The effects of mutation on the regulatory properties of phospholamban in co-reconstituted membranes, Biochemistry, 44, 3289, 10.1021/bi047878d · doi:10.1021/bi047878d
- Cantilina, 1993, Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases: effect of phospholamban antibody on enzyme activation, J. Biol. Chem., 268, 17018, 10.1016/S0021-9258(19)85295-X · DOI · Paper page
- Trieber, 2009, Effects of phospholamban transmembrane mutants on the calcium affinity, maximal activity, and cooperativity of the sarcoplasmic reticulum calcium pump, Biochemistry, 48, 9287, 10.1021/bi900852m · DOI
- Douglas, 2005, Rapid, high-yield expression and purification of Ca2+-ATPase regulatory proteins for high-resolution structural studies, Protein Expr. Purif., 40, 118, 10.1016/j.pep.2004.11.015 · doi:10.1016/j.pep.2004.11.015
- Afara, 2006, Rational design of peptide inhibitors of the sarcoplasmic reticulum calcium pump, Biochemistry, 45, 8617, 10.1021/bi0523761 · doi:10.1021/bi0523761
- Ceholski, 2012, Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A, J. Biol. Chem., 287, 26596, 10.1074/jbc.M112.382713 · DOI · Paper page
- Ceholski, 2012, Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy, J. Biol. Chem., 287, 16521, 10.1074/jbc.M112.360859 · DOI · Paper page
- Young, 2001, Locating phospholamban in co-crystals with Ca2+-ATPase by cryoelectron microscopy, Biophys. J., 81, 884, 10.1016/S0006-3495(01)75748-7 · DOI
- Stokes, 2006, Interactions between Ca2+-ATPase and the pentameric form of phospholamban in two-dimensional co-crystals, Biophys. J., 90, 4213, 10.1529/biophysj.105.079640 · doi:10.1529/biophysj.105.079640
- Glaves, 2011, Phosphorylation and mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium pump, J. Mol. Biol., 405, 707, 10.1016/j.jmb.2010.11.014 · DOI
- Ferrington, 2002, Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum, Biochemistry, 41, 13289, 10.1021/bi026407t · DOI · Paper page
- Negash, 1996, Phosphorylation of phospholamban by cAMP-dependent protein Kinase enhances interactions between Ca-ATPase polypeptide chains in cardiac sarcoplasmic reticulum membranes, Biochemistry, 35, 11247, 10.1021/bi960864q · DOI
- Becucci, 2009, The role of sarcolipin and ATP in the transport of phosphate ion into the sarcoplasmic reticulum, Biophys. J., 97, 2693, 10.1016/j.bpj.2009.08.035 · doi:10.1016/j.bpj.2009.08.035
- Buck, 2003, Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies, Protein Expr. Purif., 30, 253, 10.1016/S1046-5928(03)00127-X · DOI
- Inesi, 1988, Kinetic and equilibrium characterization of an energy-transducing enzyme and its partial reactions, Methods Enzymol., 157, 154, 10.1016/0076-6879(88)57074-X · doi:10.1016/0076-6879(88)57074-x
- Fowler, 1989, The effects of calcium, temperature, and phospholamban phosphorylation on the dynamics of the calcium-stimulated ATPase of canine cardiac sarcoplasmic reticulum, Biochim. Biophys. Acta, 980, 348, 10.1016/0005-2736(89)90323-4 · doi:10.1016/0005-2736(89)90323-4
- Bidwell, 2011, Phospholamban binds with differential affinity to calcium pump conformers, J. Biol. Chem., 286, 35044, 10.1074/jbc.M111.266759 · DOI · Paper page
- Kimura, 1997, Phospholamban inhibitory function is enhanced by depolymerization, J. Biol. Chem., 272, 15061, 10.1074/jbc.272.24.15061 · DOI · Paper page
- Lockwood, 2003, Structure and function of integral membrane protein domains resolved by peptide-amphiphiles: application to phospholamban, Biopolymers, 69, 283, 10.1002/bip.10365 · doi:10.1002/bip.10365
- Seidel, 2008, Structural characterization of Ca2+-ATPase-bound phospholamban in lipid bilayers by solid-state nuclear magnetic resonance (NMR) spectroscopy, Biochemistry, 47, 4369, 10.1021/bi7024194 · DOI · Paper page
- Reddy, 1996, Purified, reconstituted cardiac Ca2+-ATPase is regulated by phospholamban but not by direct phosphorylation with Ca2+/calmodulin-dependent protein kinase, J. Biol. Chem., 271, 14964, 10.1074/jbc.271.25.14964 · DOI
- Thomas, 1998, Direct spectroscopic detection of molecular dynamics and interactions of the calcium pump and phospholamban, Ann. N.Y. Acad. Sci., 853, 186, 10.1111/j.1749-6632.1998.tb08266.x · DOI
- Reddy, 1999, Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study, Biochemistry, 38, 3954, 10.1021/bi981795d · doi:10.1021/bi981795d
- Karim, 2001, Role of cysteine residues in structural stability and function of a transmembrane helix bundle, J. Biol. Chem., 276, 38814, 10.1074/jbc.M104006200 · doi:10.1074/jbc.m104006200
- Reddy, 2003, Defining the molecular components of calcium transport regulation in a reconstituted membrane system, Biochemistry, 42, 4585, 10.1021/bi026995a · DOI · Paper page
- Reddy, 1999, Co-reconstitution of phospholamban mutants with the Ca-ATPase reveals dependence of inhibitory function on phospholamban structure, J. Biol. Chem., 274, 7649, 10.1074/jbc.274.12.7649 · doi:10.1074/jbc.274.12.7649
- Karim, 2000, Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase, Biochemistry, 39, 10892, 10.1021/bi0003543 · DOI
- Kimura, 1996, Phospholamban regulates the Ca2+-ATPase through intramembrane interactions, J. Biol. Chem., 271, 21726, 10.1074/jbc.271.36.21726 · DOI
- Morita, 2008, Interaction sites among phospholamban, sarcolipin, and the sarco(endo)plasmic reticulum Ca2+-ATPase, Biochem. Biophys. Res. Commun., 369, 188, 10.1016/j.bbrc.2007.11.098 · DOI · Paper page
- Chen, 2006, Cross-linking of C-terminal residues of phospholamban to the Ca2+ pump of cardiac sarcoplasmic reticulum to probe spatial and functional interactions within the transmembrane domain, J. Biol. Chem., 281, 14163, 10.1074/jbc.M601338200 · DOI · Paper page
- Sharma, 2010, Endoplasmic reticulum protein targeting of phospholamban: a common role for an N-terminal di-arginine motif in ER retention?, PLoS One, 5, e11496, 10.1371/journal.pone.0011496 · DOI
- Kimura, 1998, Phospholamban domain Ib mutations influence functional interactions with the Ca2+-ATPase isoform of cardiac sarcoplasmic reticulum, J. Biol. Chem., 273, 14238, 10.1074/jbc.273.23.14238 · DOI · Paper page
- Cornea, 1997, Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers, Biochemistry, 36, 2960, 10.1021/bi961955q · DOI · Paper page
- Toyoshima, 2002, Structural changes in the calcium pump accompanying the dissociation of calcium, Nature, 418, 605, 10.1038/nature00944 · DOI · Paper page
- Toyoshima, 2003, Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase, Proc. Natl. Acad. Sci. U.S.A., 100, 467, 10.1073/pnas.0237326100 · DOI · Paper page
Cited by
Wang, S., Gopinath, T., Larsen, E. K., Weber, D. K., Walker, C., Uddigiri, V. R., Mote, K. R., Sahoo, S. K., Periasamy, M., & Veglia, G. (2021) · Science Advances · doi:10.1126/sciadv.abi7154 · Cited by 26
Metadata
- Authors
- Gorski, P. A., Glaves, J. P., Vangheluwe, P., & Young, H. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 288
- Issue
- 12
- Pages
- 8456-8467
- ISSN
- 0021-9258
- Cited by
- 73
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2775 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sarco(endo)plasmic Reticulum Calcium ATPase (SERCA) Inhibition by Sarcolipin Is Encoded in Its Luminal Tail. https://app.cochat.ai/papers/10.1074/jbc.m112.446161
- The paper
- Gorski, P. A., Glaves, J. P., Vangheluwe, P., & Young, H. S. (2013). Sarco(endo)plasmic Reticulum Calcium ATPase (SERCA) Inhibition by Sarcolipin Is Encoded in Its Luminal Tail. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m112.446161
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.